SavedAdd your journal

Journals / Göztepe Tıp Dergisi / 2013 / Cilt: 28 - Sayı: 1

İstanbul’da bir eğitim ve araştırma hastanesi yoğun bakım ünitesinde ventilator ilişkili pnömoninin etyoloji, insidans ve risk faktörleri

Etiology, incidence and risk factors of ventilator associated pneumonia in an intensive care unit of a training and research hospital in Istanbul

Elif TİGEN
Arzu DOĞRU
Fatma SARGIN
Melek GURA
Ayşe Esra SAĞIROĞLU
havva SAYHAN
Pages
14–18
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Of the 21 risk factors eva-luated, 7 factors identified were independently associated withVAP (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this prospective study, we aimed to identify the factors asso-ciated with the development of ventilator- associated pneumo-nia (VAP) and examine the etiology, and incidence of VAP.Between November 2007 and June 2008, 148 patients whorequired mechanical ventilation for longer than 48 hours wereevaluated.
📊
Key Findings & Data:VAP was observed in 54 patients (36 %).Mechanical ventilator utilizationrate was 0.87, and VAP ratein 1000 ventilator days was 22.88.
💡
Conclusion & Impact:Of the 21 risk factors eva-luated, 7 factors identified were independently associated withVAP (p
🔬Design:Research Article
📍Scope:2007 Verileri
⚙️Variables:Domain Parameters

Abstract

In this prospective study, we aimed to identify the factors asso-ciated with the development of ventilator- associated pneumo-nia (VAP) and examine the etiology, and incidence of VAP.Between November 2007 and June 2008, 148 patients whorequired mechanical ventilation for longer than 48 hours wereevaluated. VAP was observed in 54 patients (36 %).Mechanical ventilator utilizationrate was 0.87, and VAP ratein 1000 ventilator days was 22.88. The most common threemicroorganisms cultured from tracheal aspirates werePseudomonas aeruginosa (n=19), Acinetobacter spp.(n=11),and Staphylococcus aureus (n=10). Of the 21 risk factors eva-luated, 7 factors identified were independently associated withVAP (p

Özet

Bu prospektif çalışmada, VAP gelişimi ile ilgili faktörlerin belirlenmesi ve VAP’ın etyoloji ve insidansının değerlendiril- mesi amaçlanmıştır. Kasım 2007 ile Haziran 2008 tarihleri arasında 48 saatten daha uzun sure mekanik ventilator ihtiyacı olan 148 hasta değerlendirilmiştir. Mekanik ventilator kulla- nım oranı 0,87 ve VAP hızı 1000 ventilatör gününde 22,88 di. Trakeal aspiratlardan en sık izole edilen üç mikroorganizma Pseudomonas aeruginosa (n=19), Acinetobacter species (n=11) ve Staphylococcus aureus (n=10) tu. Değerlendirilen 21 risk faktöründen 7’si bağımsız olarak VAP ile ilişkiliydi (p

🔖

Cite This Article

TİGEN, E., DOĞRU, A., SARGIN, F., GURA, M., SAĞIROĞLU, A. E., SAYHAN, H. (2022). İstanbul’da bir eğitim ve araştırma hastanesi yoğun bakım ünitesinde ventilator ilişkili pnömoninin etyoloji, insidans ve risk faktörleri. Göztepe Tıp Dergisi, Cilt: 28 - Sayı: 1, 14–18. https://ajindex.com/articles/526074

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Gopal Katherason S, Naing L, Jaalam K, Ismail S. Baseline assessment of intensive care-acquired nosocomial infection surveillance in three adult intensive care units in Malaysia. J Infec Dev Ctries 2008;2:364-8
  2. Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, et al. The prevalence of nosoco- mial infection in intensive care units in European Prevalence of infection in intensive care unit (EPIC) Study. EPIC International Advisory Committee. JAMA 1995;274:639-44. http://dx.doi.org/10.1001/jama.1995.03530080055041 PMid:7637145 3. Vincent JL, Sakar Y, Sprung CL, Ranier VM, Reinhart K, Gerlach H, et al. Sepsis in European intensive care units: results of SOAP study. Crit Care Med 2006;34:344- 53. http://dx.doi.org/10.1097/01.CCM.0000194725.48928.3A PMid:16424713 4. Fagon JY, Chastre J, Vuagnat A, Troillet JL, Novora A, Gilbert C. Nosocomial pneumonia and mortality among patients in intensive care units. JAMA 1996;275:866-69. http://dx.doi.org/10.1001/jama.1996.03530350048033 PMid:8596225 5. Kollef MH. Ventilator-associated pneumonia: a multivari- ate analysis. JAMA 1993;270;1965-70. http://dx.doi.org/10.1001/jama.1993.03510160083034 PMid:8411554 6. Rello J, Sa-Borges M, Correa H, Leal SR, Baraibar J. Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices. Am J Re Spir Crit Care Med 1999; http://dx.doi.org/10.1164/ajrccm.160.2.9812034 PMid:10430736 7. Richards MJ, Edwards JR., Culver DH., Gaynes RP. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 1999;27:887-92. http://dx.doi.org/10.1097/00003246-199905000-00020 PMid:10362409 8. Rello J, Gallego M, Mariscl D, Sonora R, Valles J. The value of routine microbial investigation in ventilator- associated pneumonia. Am J Respir Care Med 1997;156:196-200. http://dx.doi.org/10.1164/ajrccm.156.1.9607030 PMid:9230747 9. Kollef MH., Ward S. The influence of mini-BAL cultures on patient outcomes: implications fort he antibiotic mana- gement of ventilator-associated pneumonia in the ICU. Chest 2002;113:112-20
  3. Mc Eachern R, Campbell GD. Hospital-acquired pneu- monia: epidemiology, etiology and treatment. Infect Dis Clin North Am 1998;12:761-79.
  4. National Nosocomial Infections Surveillance (NNIS) System Report. Data summary from January 1992 thro- ugh June 2004, is